Maxor National Pharmacy Services

Maxor National Pharmacy Services

Pharmacy services reducing prescription costs nationwide

Overview

Maxor National Pharmacy Services provides pharmacy services to reduce prescription costs and improve health outcomes for pharmacies, healthcare providers, and patients. Its offerings lean on advanced technology and expert insights delivered through a collaborative, multi-stakeholder approach, with revenue from service fees, prescription refills, and specialty pharmacy services. The company operates nationwide with key centers in Amarillo, Tempe, Pittsburgh, and Dallas and a workforce of about 1,000 professionals. Unlike competitors that focus on a single aspect of pharmacy care, Maxor emphasizes integrated, technology-enabled solutions and stakeholder collaboration to enhance the value of pharmacy services across the continuum of care. The goal is to lower prescription costs while improving patient health outcomes by coordinating services, leveraging data, and expanding access to specialty therapies.

Significant Headcount Growth

About Maxor National Pharmacy Services

Simplify's Rating
Why Maxor National Pharmacy Services is rated
C+
Rated C on Competitive Edge
Rated B on Growth Potential
Rated C on Differentiation

Industries

Healthcare

Company Size

501-1,000

Company Stage

N/A

Total Funding

N/A

Headquarters

Amarillo, Texas

Founded

1926

Get referred to Maxor National Pharmacy Services

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Kim Tzoumakas became CEO on January 6, 2025, adding fresh leadership.
  • June 2025 VytlOne positioning targets revenue growth, patient outcomes, and community reinvestment.
  • August 2025 VA sole-source notice showed Maxor retained niche federal-service credibility.

What critics are saying

  • Integration after January 2025 ProxsysRx and June 2025 VytlOne rebrand strains execution.
  • Health-system contracts face intense rivals from CVS Health, Cardinal Health, and independent 340B specialists.
  • If reimbursement pressure hits specialty and 340B economics, VytlOne's growth thesis breaks.

What makes Maxor National Pharmacy Services unique

  • June 9, 2025 rebrand to VytlOne unified Maxor's integrated pharmacy model nationwide.
  • January 14, 2025 ProxsysRx combination made it the largest independent pharmacy management provider.
  • The company serves hospitals, health systems, health centers, and employer organizations with full-service offerings.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Health Savings Account/Flexible Spending Account

401(k) Company Match

Paid Vacation

Professional Development Budget

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

16%
RxInsider
Jan 24th, 2025
RXinsider | ProxsysRx Announces Strategic Combination With Maxor National Pharmacy Services

January 23, 2025 | ProxsysRx: ProxsysRx Announces Strategic Combination With Maxor National Pharmacy Services posted by RXinsider Staff

Pinoy Bisnes
Jan 10th, 2025
Maxor announces the appointment of Kim Tzoumakas as new CEO and its strategic combination with ProxsysRx

PLANO, Texas, Jan. 10, 2025 /PRNewswire/ - Maxor National Pharmacy Services ("Maxor"), a leading pharmacy care solutions company, announced today that Kim Tzoumakas has been named the Company's new Chief Executive Officer and has also been appointed to the Board of Directors, effective January 6, 2025.

PR Newswire
Jan 10th, 2025
Maxor announces the appointment of Kim Tzoumakas as new CEO and its strategic combination with ProxsysRx

Simultaneously, Maxor announced its strategic combination with ProxsysRx, further accelerating the growth of Maxor's Pharmacy Services segment and positioning Maxor as the largest independent provider of pharmacy management services to health systems, hospitals, clinics, and other provider organizations.

Slice of Healthcare
Jan 5th, 2024
Maxor National Pharmacy Services Welcomes New Executive Leadership

Jessica Lee appointed as Chief Compliance and Ethics Officer, enhancing Maxor's commitment to regulatory compliance and quality.

PR Newswire
Jan 3rd, 2024
Maxor Appoints Three New Executives To Its Executive Leadership Team

Mark McCullough named Chief Financial OfficerJessica Lee named Chief Compliance and Ethics Officernamed Chief Compliance and Ethics Officer Joel Wright named President, Pharmacy ServicesPLANO, Texas, Jan. 3, 2024 /PRNewswire/ -- Maxor National Pharmacy Services ("Maxor") today announced the appointment of three new executives. Mark McCullough joins Maxor as Chief Financial Officer, Jessica Lee as Chief Compliance and Ethics Officer, and Joel Wright as President, Pharmacy Services. All three will serve on the company's executive leadership team and report to Maxor CEO, Mike Ellis.Maxor National Pharmacy Services"It's an exciting time for Maxor as we accelerate our strategy, bringing our full suite of clinically integrated pharmacy care solutions to serve our customers, their patients, and employees," said CEO, Mike Ellis. "We are deepening our bench of talent, and our leaders across our business continue to deploy our innovative, best-in-class, set of capabilities to deliver exceptional pharmacy care, lower costs, and improve patient care."Mark McCullough named Chief Financial OfficerMcCullough joins the company as Chief Financial Officer and brings more than 25 years of financial and operational leadership experience in the healthcare industry."We are pleased to welcome Mark as the new CFO of Maxor," said Ellis. "Mark has deep financial and operational expertise in pharmacy, health systems, and PBMs

Recently Posted Jobs

Sign up to get curated job recommendations

Maxor National Pharmacy Services is Hiring for 82 Jobs on Simplify!

Find jobs on Simplify and start your career today

Don't see your dream role? Check out thousands of other roles on Simplify. Browse all jobs →